Search for: "Johnson v. Abbott" Results 81 - 100 of 192
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 May 2014, 5:00 am
Abbott Labs, Inc., 444 F.3d 383, 387-88 (5th Cir. 2006), and Melder v. [read post]
24 Feb 2022, 9:03 pm by Henry Miller
Governor Abbott tweeted that instances of abuse would be referred for prosecution. [read post]
12 Jan 2024, 12:41 pm by Annsley Merelle Ward
Professor Ryan Abbott represented Dr Thaler, and has advocated widely for patents on AI-generated inventions.Attendance is free for members and new applicants for membership. [read post]
10 Dec 2016, 11:31 am by Lawrence B. Ebert
Johnson & Johnson, 745 F.2d 1437, 1449-1454, 223 U.S.P.Q. [read post]
29 Jul 2009, 6:45 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Tri-Cyclen Lo (Norgestimate, Ethinyl estradiol) – US: Johnson & Johnson, Teva settle patent infringement proceedings – the reverse of a reverse payment? [read post]
19 Apr 2016, 3:27 am by Amy Howe
Empirical SCOTUS; Kevin Johnson, who at Immigration Prof Blog concludes that “the Obama administration may come out okay in United States v. [read post]
5 Jul 2009, 2:23 pm
After a reported five hours of deliberation, the jury in Centocor Inc v Abbott Laboratories awarded the Johnson & Johnson unit $1.67 billion for Abbott's willful infringement. [read post]
26 Dec 2017, 8:45 pm by Nate Nead
It is worth noting that this list excludes Abbott’s mega-acquisition of St. [read post]
8 Dec 2007, 11:00 am
: (Peter Zura), Patent Tax: (Patent Prospector), (IP Spotlight), Patent litigation trends - survey results: (Patently'O), Admitting evidence of commercial success after KSR: (Delaware IP Law Blog), Abbott - A federal judge has stopped Abbott's attempt to add allegations to its claims against Johnson & Johnson subsidiary Cordis Corp in the ongoing drug eluting stent litigation: (IPLaw360), … [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
22 Sep 2013, 5:48 am by Robert Kreisman
Related blog posts: Johnson & Johnson to Stop Manufacturing Drug-Coated Heart Stents Federal Diversity Jurisdiction in Breach of Contract Case Stands; Nomanbhoy v. [read post]